European Archives - Page 931 of 1314 - European Medical Journal

Unpeeling the Layers of Creativity and Innovation

Creativity and innovation have been described in countless ways; the concepts mean different things to different people, but this fantastic analogy…

Lifting the curtain on patient data

How can the pharmaceutical industry lead the way in data transparency and give more patients the confidence to share their records with researchers?

So long to the sales rep? Pharma sales is changing

It has become clear that healthcare professionals don’t want to be sold to. They want to be partners with industry and be treated as such. How can the rep model evolve to stay in line with expectations?

Transjugular Intrahepatic Portosystemic Stent-Shunt (TIPSS) for Acute Variceal Bleeding: Has it Come of Age?

Despite the introduction of covered TIPSS, studies have not consistently demonstrated a survival benefit in secondary prevention…

Management of Hepatitis C in People Who Inject Drugs: Some Practical Lessons from the Frontline of the Elimination Battle

One of the critical populations in this battle to achieve elimination is people who inject drugs (PWID), who in the UK represent 85% of the hepatitis C…

EMJ Hepatology 7.1 2019

A warm welcome to all our readers to this year’s edition of EMJ Hepatology, a journal packed full of cutting-edge advancements and exciting new research.

Procedural Risk of Bleeding: Does the Management of Thrombocytopenia in Chronic Liver Disease Patients Make a Difference? A Debate

Clinical studies of the TPO-R agonist lusutrombopag included a large proportion of high-risk bleeding patients and therapy with this agent has been shown…

Vaccine Structure Could Impact Cancer Immunotherapy Success

THE EFFICACY of immunotherapy vaccines can be impacted by the structure of the vaccine regardless of its composition, a team of researchers from…

The role of biomarker testing in treatment decision making: Current and future perspectives

Prof Ahmad Awada is Head of Oncology Medicine Department at the Jules Bordet Institute, Brussels, Belgium, and specialises in the…

Cancer Treatment Response Could be Predicted by Tumour Mutations

TUMOUR mutations could be used to predict patients’ responses to cancer treatment drugs, according to the results of a recent study…